Patients after recovering from Covid-19 can suffer from neurological symptoms and “brain fog,” due to post-traumatic stress disorder (PTSD), according to a new study.
The study suggests that people who have recovered from Covid-19 sometimes have persistent difficulty with concentration, headaches, anxiety, fatigue, or difficulty sleeping, according to Neurosciencenews.com.
Neuropsychologist and clinical professor Andrew Levine, of David Geffen School of Medicine at the University of California, Los Angeles, and graduate student Erin Kaseda of Rosalind Franklin University of Medicine and Science, in Chicago, US, jointly conducted the study.
The paper was published in The Clinical Neuropsychologist.
During the study, the researchers looked at the data of the survivors of previous coronaviruses that caused Middle East respiratory syndrome (Mers) and Severe Acute Respiratory Syndrome (Sars).
In a statement, Dr Levin said: “The idea is to raise awareness among neuropsychologists that PTSD is something you might want to consider when evaluating persistent cognitive and emotional difficulties among Covid-19 survivors.”
“When we see someone for neuropsychological testing, we expect them to be at their best, relatively speaking,” Dr Levin said. “If we identify a psychiatric illness during our evaluation, and if we believe that condition's symptoms are interfering with their ability to perform at their best, we would want that treated first and then retest them once it's under control.”
By examining psychiatric conditions such as PTSD, researchers believe that a clearer image will emerge, which will give insight into the underlying brain problems.
Kaseda said: “Once they have treatment, and hopefully have some remission of their psychiatric symptoms, if the cognitive complaints and the deficits on neuropsychological tests are still there, then that's more evidence that something else is going on.”
She further added: “It’s going to be important for clinicians across the board to be keeping up with the literature that’s coming out, to make sure they have the most up to date information as these survivors are starting to present for neuropsychological testing.”
Kaseda further added for months or years after the initial injury, these effects continue due to the existence of a psychological disorder.
An analysis of Sars and Mers epidemic information found that the survivors of those diseases were at higher risk of suffering PTSD.
In the case of Covid-19, the symptoms of PTSD may arise if the patients need invasive treatment measures, such as intubation and ventilation.
Covid-19 patients can experience delirium too, which may lead to hallucinations, and the memory of that experience can cause trauma as well.
While a PTSD diagnosis sounds worrying, there are treatment options available for the disorder, including psychotherapy and medications. By comparison, researchers are still working to understand the direct neurological effects of Covid-19.
“Treatment options [for Covid-19] are still quite a way’s out, because it’s still an evolving situation,” Kaseda said. “We don’t actually know anything yet from survivors of Covid-19. Until we have that data, it’s very hard to say what actual percentage of patients are going to have cognitive complaints because of direct effects of the virus, because of medical intervention, or because of psychiatric concerns.”